Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2024

Jul 17, 2024

35146_dirs_2024-07-17_1c4c8ba2-d3b3-476a-8bfd-4e793373631e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2024-07-15

Reporting Person: Accelmed Partners, L.P. (10% Owner)
Reporting Person: Accelmed Partners (GP), L.P. (10% Owner)
Reporting Person: Accelmed Growth Partners (AGP) Ltd (10% Owner)
Reporting Person: Accelmed Growth Partners Management Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-07-15 Common Stock P 230573 $3.14 Acquired 1441835 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1441835 Indirect
Common Stock 1441835 Indirect
Common Stock 1441835 Indirect

Footnotes

F1: Shares are held directly by Accelmed Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Partners (GP), L.P., the general partner of Accelmed Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of their pecuniary interest in the shares of common stock held by Accelmed Partners, L.P.